Literature DB >> 33679755

The Emerging Role of Microglia in Neuromyelitis Optica.

Tingjun Chen1, Dale B Bosco1, Yanlu Ying1, Dai-Shi Tian2, Long-Jun Wu1,3,4.   

Abstract

Neuromyelitis optica (NMO) is an autoantibody-triggered neuro-inflammatory disease which preferentially attacks the spinal cord and optic nerve. Its defining autoantibody is specific for the water channel protein, aquaporin-4 (AQP4), which primarily is localized at the end-feet of astrocytes. Histopathology studies of early NMO lesions demonstrated prominent activation of microglia, the resident immune sentinels of the central nervous system (CNS). Significant microglial reactivity is also observed in NMO animal models induced by introducing AQP4-IgG into the CNS. Here we review the potential roles for microglial activation in human NMO patients as well as different animal models of NMO. We will focus primarily on the molecular mechanisms underlying microglial function and microglia-astrocyte interaction in NMO pathogenesis. Understanding the role of microglia in NMO pathology may yield novel therapeutic approaches for this disease.
Copyright © 2021 Chen, Bosco, Ying, Tian and Wu.

Entities:  

Keywords:  C3a receptor; aquaporin-4; astrocyte-microglia communication; autoimmune; complement C3; microglia; neuromyelitis optica

Mesh:

Substances:

Year:  2021        PMID: 33679755      PMCID: PMC7933531          DOI: 10.3389/fimmu.2021.616301

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   8.786


  146 in total

Review 1.  Cien Años de Microglía: Milestones in a Century of Microglial Research.

Authors:  Amanda Sierra; Rosa C Paolicelli; Helmut Kettenmann
Journal:  Trends Neurosci       Date:  2019-10-18       Impact factor: 13.837

2.  Activation of mGluR1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer's Rodent Models.

Authors:  Bihua Bie; Jiang Wu; Joseph F Foss; Mohamed Naguib
Journal:  Mol Neurobiol       Date:  2019-01-16       Impact factor: 5.590

3.  Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.

Authors:  Sean J Pittock; Achim Berthele; Kazuo Fujihara; Ho Jin Kim; Michael Levy; Jacqueline Palace; Ichiro Nakashima; Murat Terzi; Natalia Totolyan; Shanthi Viswanathan; Kai-Chen Wang; Amy Pace; Kenji P Fujita; Róisín Armstrong; Dean M Wingerchuk
Journal:  N Engl J Med       Date:  2019-05-03       Impact factor: 91.245

4.  Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist.

Authors:  Diane L Sewell; Brendon Nacewicz; Frances Liu; Sinarack Macvilay; Anna Erdei; John D Lambris; Matyas Sandor; Zsuzsa Fabry
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478

5.  A complement-microglial axis drives synapse loss during virus-induced memory impairment.

Authors:  Michael J Vasek; Charise Garber; Denise Dorsey; Douglas M Durrant; Bryan Bollman; Allison Soung; Jinsheng Yu; Carlos Perez-Torres; Arnaud Frouin; Daniel K Wilton; Kristen Funk; Bette K DeMasters; Xiaoping Jiang; James R Bowen; Steven Mennerick; John K Robinson; Joel R Garbow; Kenneth L Tyler; Mehul S Suthar; Robert E Schmidt; Beth Stevens; Robyn S Klein
Journal:  Nature       Date:  2016-06-23       Impact factor: 49.962

6.  Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus.

Authors:  Ukpong B Eyo; Jiyun Peng; Przemyslaw Swiatkowski; Aparna Mukherjee; Ashley Bispo; Long-Jun Wu
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

7.  Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis.

Authors:  Harleen Saini; Robert Rifkin; Michael Gorelik; Hwa Huang; Zachary Ferguson; Melina V Jones; Michael Levy
Journal:  BMC Neurol       Date:  2013-08-08       Impact factor: 2.474

8.  Complement C5a receptor knockout has diminished light-induced microglia/macrophage retinal migration.

Authors:  Delu Song; Michael E Sulewski; Chenguang Wang; Jiantao Song; Rupak Bhuyan; Jacob Sterling; Esther Clark; Wen-Chao Song; Joshua L Dunaief
Journal:  Mol Vis       Date:  2017-04-10       Impact factor: 2.367

9.  Resolving and Rescuing Developmental Miswiring in a Mouse Model of Cognitive Impairment.

Authors:  Mattia Chini; Jastyn A Pöpplau; Christoph Lindemann; Laura Carol-Perdiguer; Marilena Hnida; Victoria Oberländer; Xiaxia Xu; Joachim Ahlbeck; Sebastian H Bitzenhofer; Christoph Mulert; Ileana L Hanganu-Opatz
Journal:  Neuron       Date:  2019-11-13       Impact factor: 17.173

10.  Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.

Authors:  Kazuhiro Kurosawa; Tatsuro Misu; Yoshiki Takai; Douglas Kazutoshi Sato; Toshiyuki Takahashi; Yoichiro Abe; Hiroko Iwanari; Ryo Ogawa; Ichiro Nakashima; Kazuo Fujihara; Takao Hamakubo; Masato Yasui; Masashi Aoki
Journal:  Acta Neuropathol Commun       Date:  2015-12-04       Impact factor: 7.801

View more
  5 in total

Review 1.  Chemogenetic and Optogenetic Manipulations of Microglia in Chronic Pain.

Authors:  Sebastian Parusel; Min-Hee Yi; Christine L Hunt; Long-Jun Wu
Journal:  Neurosci Bull       Date:  2022-08-17       Impact factor: 5.271

2.  Differences in Neuropathic Pain and Radiological Features Between AQP4-ON, MOG-ON, and IDON.

Authors:  Hao Kang; Huaiyu Qiu; Xiaofeng Hu; Shihui Wei; Yong Tao
Journal:  Front Pain Res (Lausanne)       Date:  2022-05-09

Review 3.  The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders.

Authors:  Wenqun Li; Jiaqin Liu; Wei Tan; Yedi Zhou
Journal:  Int J Med Sci       Date:  2021-06-16       Impact factor: 3.738

4.  Efficacy of Plasma Exchange Treatment for Demyelinating Optic Neuritis Associated with Various Serum Antibodies: A Prospective Cohort Study.

Authors:  Junxia Fu; Yongping Wang; Hongen Li; Huanfen Zhou; Honglu Song; Mingming Sun; Quangang Xu; Shaoying Tan; Shihui Wei
Journal:  Neurol Ther       Date:  2022-04-09

5.  Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis.

Authors:  Xinyan Dong; Jianchen Fan; Donghui Lin; Xuehui Wang; Haoyu Kuang; Lifen Gong; Chen Chen; Jie Jiang; Ningxiao Xia; Dahong He; Weida Shen; Peifang Jiang; Rong Kuang; Linghui Zeng; Yicheng Xie
Journal:  J Neuroinflammation       Date:  2022-09-14       Impact factor: 9.587

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.